Estimación del riesgo | 12 ENE 15

Esplenectomia y riesgo de sepsis

Se busca estimar el riesgo de sepsis a largo plazo en pacientes que fueron previamente sometidos a esplenectomía, antes, durante y después de la implementación de vacunación rutinaria contra bacterias encapsuladas.
1
8
Autor/a: Edgren G, Almqvist R, Hartman M, Utter G Ann Surg 2014; 260(6): 1081-1087
INDICE:  1. Desarrollo | 2. Bibliografía
Bibliografía

1. Morris DH, Bullock FD. The importance of the spleen in resistance to infection. Ann Surg. 1919;70:513–521.
2. Eraklis AJ, Kevy SV, Diamond LK, et al. Hazard of overwhelming infection after splenectomy in childhood. N Engl J Med. 1967;276:1225–1229.
3. Zarrabi MH, Rosner F. Serious infections in adults following splenectomy for trauma. Arch Intern Med. 1984;144:1421–1424.
4. Styrt B. Infection associated with asplenia: risks, mechanisms, and prevention. Am J Med. 1990;88:33N-42N.
5. Spelman D, Buttery J, Daley A, et al. Guidelines for the prevention of sepsis in asplenic and hyposplenic patients. Intern Med J. 2008;38:349–356.
6. Bisharat N, Omari H, Lavi I, et al. Risk of infection and death among post-splenectomy patients. J Infect. 2001;43:182–186.
7. Thomsen RW, Schoonen WM, Farkas DK, et al. Risk for hospital contact with infection in patients with splenectomy: a population-based cohort study. Ann Intern Med. 2009;151:546–555.
8. Reid MM. Splenectomy, sepsis, immunisation, and guidelines. Lancet. 1994;344:970–971.
9. Shatz DV. Vaccination considerations in the asplenic patient. Expert Rev Vaccines. 2005;4:27–34.
10. Rosner F, Zarrabi MH, Benach JL, et al. Babesiosis in splenectomized adults. Review of 22 reported cases. Am J Med. 1984;76:696–701.
11. Ejstrud P, Kristensen B, Hansen JB, et al. Risk and patterns of bacteraemia after splenectomy: a population-based study. Scand J Infect Dis. 2000;32:521–525.
12. Sarangi J, Coleby M, Trivella M, et al. Prevention of post splenectomy sepsis: a population based approach. J Public Health Med. 1997;19:208–212.
13. Yong M, Thomsen RW, Schoonen WM, et al. Mortality risk in splenectomised patients: a Danish population-based cohort study. Eur J Intern Med. 2010;21:12–16.
14. Davies JM, Barnes R, Milligan D. Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Clin Med. 2002;2:440–443.
15. El-Alfy MS, El-Sayed MH. Overwhelming postsplenectomy infection: is quality of patient knowledge enough for prevention? Hematol J. 2004;5:77–80.
16. Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.
17. Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, et al. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24:659–667.
18. Ulm K. A simple method to calculate the confidence interval of a standardized mortality ratio (SMR). Am J Epidemiol. 1990;131:373–375.
19. Fedson DS. Pneumococcal vaccination in the United States and 20 other developed countries, 1981–1996. Clin Infect Dis. 1998;26:1117–1123.
20. Hallander HO, Lepp T, Ljungman M, et al. Do we need a booster of Hib vaccine after primary vaccination? A study on anti-Hib seroprevalence in Sweden 5 and 15 years after the introduction of universal Hib vaccination related to notifications of invasive disease. APMIS. 2010;118:878–887.
21. Boshuizen HC, Feskens EJ. Fitting additive Poisson models. Epidemiol Perspect Innov. 2010;7:4.
22. Gooley TA, Leisenring W, Crowley J, et al. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18:695–706.
23. Kalbfleisch JDaP, Ross L. The Statistical Analysis of Failure Time Data. 2nd ed. In: Hoboken NW, ed. Hoboken, NJ: Wiley; 2002.
24. Konradsen HB, Henrichsen J. Pneumococcal infections in splenectomized children are preventable. Acta Paediatr Scand. 1991;80:423–427.
25. Meerveld-Egginka A, deWeerdta O, Rijkersb GT, et al. Vaccination coverage and awareness of infectious risks in patients with an absent or dysfunctional spleen in the Netherlands. Vaccine. 2008;26:6975–6979.
26. Lammers J, Veninga D, Speelman P, et al. Performance of Dutch hospitals in the management of splenectomized patients. J Hosp Med. 2010;5:466–470.
27. Kyaw MH, Holmes EM, Chalmers J, et al. A survey of vaccine coverage and antibiotic prophylaxis in splenectomised patients in Scotland. J Clin Pathol. 2002;55:472–474.
28. Bruni L, Bayas JM, Vilella A, et al. Vaccination coverage in adults undergoing splenectomy: evaluation of hospital vaccination policies. Epidemiol Infect. 2006;134:837–844.
 

 

Comentarios

Usted debe ingresar al sitio con su cuenta de usuario IntraMed para ver los comentarios de sus colegas o para expresar su opinión. Si ya tiene una cuenta IntraMed o desea registrase, ingrese aquí

AAIP RNBD
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2020